edgen-logoベータ

エドとチャットする

Invest

Brief

Desk
その他

ニュース

発見

ポートフォリオ
ミッション
フォローする

参加する

EN
戻る


healthcare: pharmaニュース

あなたのために市場経済テクノロジーとAI暗号資産エネルギー医療香港および中国ファイナンス

製薬

バイオテクノロジー

保健サービス

医療機器

BioMarin beats Q2 estimates, lifts 2026 outlook on 20% revenue growth

BioMarin beats Q2 estimates, lifts 2026 outlook on 20% revenue growth

Aug 07 2026, 17:08
TransThera shares jump 14% on China approval of tinengotinib

TransThera shares jump 14% on China approval of tinengotinib

Aug 07 2026, 03:35
FDA approves Replimune's Tudriqev melanoma drug after two rejections

FDA approves Replimune's Tudriqev melanoma drug after two rejections

Aug 07 2026, 03:25
Hikma jumps 10% as H1 profit beats, brokers keep buy

Hikma jumps 10% as H1 profit beats, brokers keep buy

Aug 06 2026, 10:06
BeOne Medicines lifts 2026 outlook as Brukinsa sales jump 31%

BeOne Medicines lifts 2026 outlook as Brukinsa sales jump 31%

Aug 06 2026, 05:28
Moderna wins FDA approval for mFLUSIVA flu vaccine in adults 50+

Moderna wins FDA approval for mFLUSIVA flu vaccine in adults 50+

Aug 06 2026, 02:49
FDA approves Takeda's oveporexton, first orexin agonist for narcolepsy type 1

FDA approves Takeda's oveporexton, first orexin agonist for narcolepsy type 1

Aug 05 2026, 22:16
Lilly raises 2026 guidance as Mounjaro, Zepbound drive 48% revenue jump

Lilly raises 2026 guidance as Mounjaro, Zepbound drive 48% revenue jump

Aug 05 2026, 11:41
Gilead Q2 revenue jumps 10% as PrEP sales top $1 billion

Gilead Q2 revenue jumps 10% as PrEP sales top $1 billion

Aug 05 2026, 02:48
Novo Nordisk raises 2026 outlook after Q2 profit jumps 11%

Novo Nordisk raises 2026 outlook after Q2 profit jumps 11%

Aug 04 2026, 16:54
CRISPR Therapeutics narrows Q2 loss as Casgevy sales surge 151%

CRISPR Therapeutics narrows Q2 loss as Casgevy sales surge 151%

Aug 04 2026, 16:19
Merck raises 2026 sales forecast to $67.3B, cuts profit view

Merck raises 2026 sales forecast to $67.3B, cuts profit view

Aug 04 2026, 11:16
Regeneron faces securities suit after $11 billion melanoma trial wipeout

Regeneron faces securities suit after $11 billion melanoma trial wipeout

Aug 04 2026, 01:21
Zevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examination

Zevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examination

Aug 03 2026, 14:23
Ascletis starts Phase III obesity trial enrolling 4,600 patients

Ascletis starts Phase III obesity trial enrolling 4,600 patients

Aug 03 2026, 13:58
AstraZeneca, Bristol Myers Squibb in talks on $400 billion merger

AstraZeneca, Bristol Myers Squibb in talks on $400 billion merger

Aug 03 2026, 07:50
Sandoz settles $450 million antitrust claims with 43 US states

Sandoz settles $450 million antitrust claims with 43 US states

Aug 03 2026, 06:25
Novo Nordisk claws back into obesity race as shares climb 35%

Novo Nordisk claws back into obesity race as shares climb 35%

Aug 03 2026, 05:51
FDA approves Novartis Pluvicto, cutting prostate cancer progression risk 33%

FDA approves Novartis Pluvicto, cutting prostate cancer progression risk 33%

Jul 31 2026, 23:48
Pharming shares plunge 22% as RUCONEST sales slide 10%

Pharming shares plunge 22% as RUCONEST sales slide 10%

Jul 31 2026, 22:45

特徴
株式・暗号通貨用AIコピローター
価格予測
資金調達トラッカー
暗号通貨比較
ホームページ
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
利用規約プライバシーポリシーサイトマップ
© 2026 Edgen によって提供edgen-logo